MUSSO, Giovanni
MUSSO, Giovanni
Angiotensin II Type 1 Receptor rs5186 Gene Variant Predicts Incident NAFLD and Associated Hypertension: Role of Dietary Fat-Induced Pro-Inflammatory Cell Activation
2019-01-01 Musso, Giovanni; Saba, Francesca; Cassader, Maurizio; Paschetta, Elena; De Michieli, Franco; Pinach, Silvia; Framarin, Luciana; Berrutti, Mara; Leone, Nicola; Parente, Renato; Ayoubi Khajekini, Mohammad Taghi; Zarovska, Adriana; Gambino, Roberto
Assessing the risk of ketoacidosis due to sodium-glucose cotransporter (SGLT)-2 inhibitors in patients with type 1 diabetes: A meta-analysis and meta-regression
2020-01-01 Musso, Giovanni; Sircana, Antonio; Saba, Francesca; Cassader, Maurizio; Gambino, Roberto
Bioactive Lipid Species and Metabolic Pathways in Progression and Resolution of Nonalcoholic Steatohepatitis
2018-01-01 Musso, Giovanni*; Cassader, Maurizio; Paschetta, Elena; Gambino, Roberto
Diabetic ketoacidosis with SGLT2 inhibitors
2020-01-01 Musso, Giovanni; Saba, Francesca; Cassader, Maurizio; Gambino, Roberto
Effect of phospholipid curcumin Meriva® on liver histology and kidney disease in nonalcoholic steatohepatitis a randomized, double-blind, placebo-controlled trial
2024-01-01 Musso, Giovanni; Pinach, Silvia; Mariano, Filippo; Saba, Francesca; De Michieli, Franco; Framarin, Luciana; Berrutti, Mara; Paschetta, Elena; Parente, Renato; Lizet Castillo, Yanina; Leone, Nicola; Castellino, Francesca; Cassader, Maurizio; Gambino, Roberto
Efficacy and safety of dual SGLT 1/2 inhibitor sotagliflozin in type 1 diabetes: meta-analysis of randomised controlled trials
2019-01-01 Musso, Giovanni; Gambino, Roberto; Cassader, Maurizio; Paschetta, Elena
Emerging Liver-Kidney Interactions in Nonalcoholic Fatty Liver Disease
2015-01-01 Musso, Giovanni; Cassader, Maurizio; Cohney, Solomon; Pinach, Silvia; Saba, Francesca; Gambino, Roberto
Endoscopic duodenal mucosa ablation techniques for diabetes and nonalcoholic fatty liver disease: A systematic review
2024-01-01 Musso, Giovanni; Pinach, Silvia; Saba, Francesca; De Michieli, Franco; Cassader, Maurizio; Gambino, Roberto
Endoscopic duodenal mucosa ablation: the future of diabetes treatment?
2024-01-01 Musso, Giovanni; Cassader, Maurizio; Gambino, Roberto
Letter by Musso et al Regarding Article, "Cardiac Outcomes After Ischemic Stroke or Transient Ischemic Attack: Effects of Pioglitazone in Patients With Insulin Resistance Without Diabetes Mellitus"
2017-01-01 Musso, Giovanni; Cassader, Maurizio; Gambino, Roberto
MERTK rs4374383 variant predicts incident nonalcoholic fatty liver disease and diabetes Role of mononuclear cell activation and adipokine response to dietary fat
2017-01-01 Musso, Giovanni; Cassader, Maurizio; DE MICHIELI, Franco; Paschetta, Elena; Pinach, Silvia Vittoria; Saba, Francesca; Bongiovanni, Daria; Framarin, Luciana; Berrutti, Mara; Leone, Nicola; Corvisieri, Stefania; Parente, Renato; Molinaro, Federica; Sircana, Antonio; Bo, Simona; Gambino, Roberto
Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies
2016-01-01 Musso, Giovanni; Cassader, Maurizio; Gambino, Roberto
Recent Insight into the Role of Fibrosis in Nonalcoholic Steatohepatitis-Related Hepatocellular Carcinoma
2019-01-01 Sircana, Antonio; Paschetta, Elena; Saba, Francesca; Molinaro, Federica; Musso, Giovanni
Specialized Proresolving Mediators: Enhancing Nonalcoholic Steatohepatitis and Fibrosis Resolution
2018-01-01 Musso, Giovanni*; Gambino, Roberto; Cassader, Maurizio; Paschetta, Elena; Sircana, Antonio
Targeting mitochondrial pyruvate carrier in nonalcoholic steatohepatitis: Growing evidence and future challenges.
2018-01-01 Musso, Giovanni; Gambino, Roberto
TM6SF2 may drive postprandial cholesterol toxicity away from the vessel walls to the liver in NAFLD
2016-01-01 Musso, Giovanni; Cassader, Maurizio; Paschetta, Elena; Gambino, Roberto
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Angiotensin II Type 1 Receptor rs5186 Gene Variant Predicts Incident NAFLD and Associated Hypertension: Role of Dietary Fat-Induced Pro-Inflammatory Cell Activation | 2019 | Musso, Giovanni; Saba, Francesca; Cassader, Maurizio; Paschetta, Elena; De Michieli, Franco; Pinach, Silvia; Framarin, Luciana; Berrutti, Mara; Leone, Nicola; Parente, Renato; Ayoubi Khajekini, Mohammad Taghi; Zarovska, Adriana; Gambino, Roberto | |
| Assessing the risk of ketoacidosis due to sodium-glucose cotransporter (SGLT)-2 inhibitors in patients with type 1 diabetes: A meta-analysis and meta-regression | 2020 | Musso, Giovanni; Sircana, Antonio; Saba, Francesca; Cassader, Maurizio; Gambino, Roberto | |
| Bioactive Lipid Species and Metabolic Pathways in Progression and Resolution of Nonalcoholic Steatohepatitis | 2018 | Musso, Giovanni*; Cassader, Maurizio; Paschetta, Elena; Gambino, Roberto | |
| Diabetic ketoacidosis with SGLT2 inhibitors | 2020 | Musso, Giovanni; Saba, Francesca; Cassader, Maurizio; Gambino, Roberto | |
| Effect of phospholipid curcumin Meriva® on liver histology and kidney disease in nonalcoholic steatohepatitis a randomized, double-blind, placebo-controlled trial | 2024 | Musso, Giovanni; Pinach, Silvia; Mariano, Filippo; Saba, Francesca; De Michieli, Franco; Framarin, Luciana; Berrutti, Mara; Paschetta, Elena; Parente, Renato; Lizet Castillo, Yanina; Leone, Nicola; Castellino, Francesca; Cassader, Maurizio; Gambino, Roberto | |
| Efficacy and safety of dual SGLT 1/2 inhibitor sotagliflozin in type 1 diabetes: meta-analysis of randomised controlled trials | 2019 | Musso, Giovanni; Gambino, Roberto; Cassader, Maurizio; Paschetta, Elena | |
| Emerging Liver-Kidney Interactions in Nonalcoholic Fatty Liver Disease | 2015 | Musso, Giovanni; Cassader, Maurizio; Cohney, Solomon; Pinach, Silvia; Saba, Francesca; Gambino, Roberto | |
| Endoscopic duodenal mucosa ablation techniques for diabetes and nonalcoholic fatty liver disease: A systematic review | 2024 | Musso, Giovanni; Pinach, Silvia; Saba, Francesca; De Michieli, Franco; Cassader, Maurizio; Gambino, Roberto | |
| Endoscopic duodenal mucosa ablation: the future of diabetes treatment? | 2024 | Musso, Giovanni; Cassader, Maurizio; Gambino, Roberto | |
| Letter by Musso et al Regarding Article, "Cardiac Outcomes After Ischemic Stroke or Transient Ischemic Attack: Effects of Pioglitazone in Patients With Insulin Resistance Without Diabetes Mellitus" | 2017 | Musso, Giovanni; Cassader, Maurizio; Gambino, Roberto | |
| MERTK rs4374383 variant predicts incident nonalcoholic fatty liver disease and diabetes Role of mononuclear cell activation and adipokine response to dietary fat | 2017 | Musso, Giovanni; Cassader, Maurizio; DE MICHIELI, Franco; Paschetta, Elena; Pinach, Silvia Vittoria; Saba, Francesca; Bongiovanni, Daria; Framarin, Luciana; Berrutti, Mara; Leone, Nicola; Corvisieri, Stefania; Parente, Renato; Molinaro, Federica; Sircana, Antonio; Bo, Simona; Gambino, Roberto | |
| Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies | 2016 | Musso, Giovanni; Cassader, Maurizio; Gambino, Roberto | |
| Recent Insight into the Role of Fibrosis in Nonalcoholic Steatohepatitis-Related Hepatocellular Carcinoma | 2019 | Sircana, Antonio; Paschetta, Elena; Saba, Francesca; Molinaro, Federica; Musso, Giovanni | |
| Specialized Proresolving Mediators: Enhancing Nonalcoholic Steatohepatitis and Fibrosis Resolution | 2018 | Musso, Giovanni*; Gambino, Roberto; Cassader, Maurizio; Paschetta, Elena; Sircana, Antonio | |
| Targeting mitochondrial pyruvate carrier in nonalcoholic steatohepatitis: Growing evidence and future challenges. | 2018 | Musso, Giovanni; Gambino, Roberto | |
| TM6SF2 may drive postprandial cholesterol toxicity away from the vessel walls to the liver in NAFLD | 2016 | Musso, Giovanni; Cassader, Maurizio; Paschetta, Elena; Gambino, Roberto |